Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minimizing factor requirements for surgery without increased risk.

S Schulman1, J Loogna, R Wallensten

  • 1Department of Hematology, Coagulation Unit, Karolinska University Hospital, S-171 76 Stockholm, Sweden. schulms@mcmaster.ca

Haemophilia : the Official Journal of the World Federation of Hemophilia
|October 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients.

Medicina intensiva·2021
Same author

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients.

Medicina intensiva·2021
Same author

Associations of thrombocytopenia, transaminase elevations, and transfusion with laboratory coagulation tests in women with preeclampsia: a cross-sectional study.

International journal of obstetric anesthesia·2021
Same author

Lemierre syndrome - treat with antibiotics, anticoagulants or both?

Journal of internal medicine·2020
Same author

Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials.

Journal of thrombosis and haemostasis : JTH·2017
Same journal

Male Range of Motion Norms in the Haemophilia Joint Health Score Underrepresent the Severity of Joint Damage in Females.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Physical Activity and Sedentary Behaviour in Children With Haemophilia.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Ten-year Demographic and Clinical Characterisation of People With Haemophilia: The Colombian Registry Experience.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Exploratory Claims-Based Assessment of Diagnosed and Potentially Undiagnosed von Willebrand Disease in Japan.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Use of an Oral Health-Related Quality of Life Instrument to Measure Unmet Dental Care Needs in Adults With Inherited Bleeding Disorders.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same journal

Clinical Factors for Predicting Synovial Hypertrophy in Early Haemophilic Arthropathy on Prophylaxis: A Cross-Sectional Study of Patient- and Joint-Level Analyses Using Musculoskeletal Ultrasound.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
See all related articles

This study demonstrates that reducing factor concentrate levels to 0.5 IU mL(-1) during orthopaedic surgery for haemophilia patients does not increase blood loss or complications. This finding supports more resource-efficient treatment protocols for haemophilia care.

Area of Science:

  • Orthopaedic Surgery
  • Haematology
  • Patient Care

Background:

  • Orthopaedic surgery, particularly on the lower limb, is common in haemophilia patients.
  • These procedures significantly improve quality of life but require substantial factor concentrate resources, which are often scarce globally.

Purpose of the Study:

  • To investigate if reduced factor concentrate levels during and after total hip or knee replacement in haemophilia patients compromise procedural outcomes.
  • To explore strategies for minimizing factor concentrate usage in orthopaedic haemophilia care.

Main Methods:

  • Analysis of 30 orthopaedic procedures (total hip/knee replacement) in 27 haemophilia patients.
  • Monitoring steady-state factor levels, with a target as low as 0.5 IU mL(-1).
  • Comparison of blood loss and complication incidence with higher factor level protocols.

Related Experiment Videos

Main Results:

  • Maintaining steady-state factor levels down to 0.5 IU mL(-1) did not lead to increased blood loss or complications compared to higher levels.
  • The study presents data from 30 orthopaedic procedures in 27 patients.

Conclusions:

  • Lowering factor concentrate levels to 0.5 IU mL(-1) appears safe for orthopaedic surgery in haemophilia patients.
  • Combining orthopaedic procedures and utilizing local haemostatic or antifibrinolytic agents are viable methods to reduce factor concentrate requirements.